Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

B&L PureVision Sales Injunction Stands; Firm Eyes Appeals Court Reversal

This article was originally published in The Gray Sheet

Executive Summary

Bausch & Lomb will need to find a foreign manufacturing site for its PureVision extended-wear contact lenses if the Washington, D.C. Court of Appeals for the Federal Circuit (CAFC) upholds a June 26 Delaware federal court ruling prohibiting manufacture and sale of the lenses in the U.S

You may also be interested in...



Wesley Jessen Wins PureVision Patent Suit; B&L Weighs Limited Options

Bausch & Lomb is prohibited from selling its PureVision extended-wear contact lenses in the U.S. following a Washington, D.C. federal appeals court ruling Feb. 12

Wesley Jessen Wins PureVision Patent Suit; B&L Weighs Limited Options

Bausch & Lomb is prohibited from selling its PureVision extended-wear contact lenses in the U.S. following a Washington, D.C. federal appeals court ruling Feb. 12

B&L Awaits PureVision Court Decision; Restructuring Plan Cuts 450 Jobs

Bausch & Lomb does not expect a significant impact on sales of its PureVision extended-wear contact lenses abroad regardless of whether a federal court of appeals grants the firm a stay of an injunction on U.S. sales of the product line

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016787

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel